Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug repositioning for orphan genetic diseases through Conserved Anticoexpressed Gene Clusters (CAGCs).

BMC bioinformatics - 2 Oct 2013

Molineris Ivan, Ala Ugo, Provero Paolo, Di Cunto Ferdinando

Abstract excerpt

BACKGROUND: The development of new therapies for orphan genetic diseases represents an extremely important medical and social challenge. Drug repositioning, i.e. finding new indications for approved drugs, could be one of the most cost- and time-effective strategies to cope with this problem, at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Biology
Share to Disease
Share to Drug Repositioning

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy

Share to Gene Expression

Share to Gene Expression Profiling

Share to Multigene Family

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 24088245
DOI: 10.1186/1471-2105-14-288
PMCID: PMC3851137

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24088245-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug repositioning for orphan genetic diseases through Conserved Anticoexpressed Gene Clusters (CAGCs).PMID 24088245Read ↗

Drug target gene-based analyses of drug repositionability in rare and intractable diseases.Semantic proximity Read ↗

Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data.Semantic proximity Read ↗

Transcriptional data: a new gateway to drug repositioning?Semantic proximity Read ↗

Computational drug repositioning through heterogeneous network clustering.Semantic proximity Read ↗

Target-Based Drug Repositioning Using Large-Scale Chemical-Protein Interactome Data.Semantic proximity Read ↗

Drug repositioning using disease associated biological processes and network analysis of drug targets.Semantic proximity Read ↗

Drug Repositioning Identifies Six Drug Candidates for Systemic Autoimmune Diseases by Integrative Analyses of Transcriptomes from Scleroderma, Systemic Lupus Erythematosus, and Sjogren's SyndromeSemantic proximity Read ↗

Changing Trends in Computational Drug RepositioningSemantic proximity Read ↗

Drug Repositioning by Merging Active Subnetworks Validated in Cancer and COVID-19Semantic proximity Read ↗

Prediction of human disease genes by human-mouse conserved coexpression analysis.Semantic proximity Read ↗

Toxicogenomic identification of repositioned therapy for a monogenic diseaseSemantic proximity Read ↗

A survey of current trends in computational drug repositioning.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.